Atara Biotherapeutics resubmits tab-cel application to FDA

Go back to Atara Biotherapeutics resubmits tab-cel application to FDA
(NASDAQ: ATRA) Delayed: 7.81 --0 (-0%)
Previous Close $7.81    52 Week High $40.80 
Open $7.81    52 Week Low $12.45 
Day High $7.81    P/E N/A 
Day Low $7.81    EPS $0.00 
Volume 28